Health Care & Life Sciences » Pharmaceuticals | Syndax Pharmaceuticals Inc.

Syndax Pharmaceuticals Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
-
-
627.00
1,220.00
2,108.00
1,517
Cost of Goods Sold (COGS) incl. D&A
13.00
15.00
-
-
-
-
Gross Income
13.00
15.00
-
-
-
-
SG&A Expense
8,558.00
21,317.00
21,119.00
44,897.00
63,986.00
77,315
EBIT
8,571.00
21,332.00
20,513.00
43,766.00
61,954.00
75,876
Unusual Expense
4,959.00
1,793.00
2,162.00
1,703.00
-
-
Non Operating Income/Expense
130.00
-
30.00
41.00
269.00
27
Interest Expense
771.00
299.00
1,575.00
-
-
-
Pretax Income
14,171.00
19,828.00
24,119.00
44,472.00
60,802.00
73,961
Consolidated Net Income
60,454.00
19,828.00
24,119.00
44,472.00
60,802.00
73,961
Net Income
60,454.00
19,828.00
24,119.00
44,472.00
60,802.00
73,961
Net Income After Extraordinaries
60,454.00
19,828.00
24,119.00
44,472.00
60,802.00
73,961
Net Income Available to Common
60,454.00
26,357.00
103,845.00
47,070.00
60,802.00
73,961
EPS (Basic)
1.43
1.46
5.76
3.22
2.90
2.92
Basic Shares Outstanding
42,186.70
18,032.70
18,032.70
14,619.70
20,997.20
25,371.50
EPS (Diluted)
1.43
1.46
5.76
3.22
2.90
2.92
Diluted Shares Outstanding
42,186.70
18,032.70
18,032.70
14,619.70
20,997.20
25,371.50
EBITDA
8,558.00
21,317.00
20,492.00
43,677.00
61,878.00
75,798
Non-Operating Interest Income
-
10.00
161.00
956.00
1,421.00
1,942
Other After Tax Income (Expense)
46,283.00
-
-
-
-
-
Preferred Dividends
-
6,529.00
79,726.00
2,598.00
-
-

About Syndax Pharmaceuticals

View Profile
Address
35 Gatehouse Drive
Waltham Massachusetts 02451
United States
Employees -
Website http://www.syndax.com
Updated 07/08/2019
Syndax Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development of cancer therapies. Its products include candidate and entinostat. The company was founded by Richard A.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.